Estrogen and lipid profile in patients with endometriosis treated by GnRH agonist

International Journal of Gynecology and Obstetrics

Volumn 66, Issue 2, 1999, Pages 191-192

  Al Omari, W R ^a   Nassir, U N ^a   Sulaiman, W R ^b  

^a BAGHDAD TEACHING HOSPITAL   (Iraq)

^b UNIVERSITY OF BAGHDAD   (Iraq)

Author keywords

Endometriosis; Estradiol; GnRH agonist; Lipid profile

Indexed keywords

ESTRADIOL; ESTROGEN; GONADORELIN AGONIST; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; TRIPTORELIN;

ADULT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOMETRIOSIS; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INTRAMUSCULAR DRUG ADMINISTRATION; LIPID ANALYSIS; NORMAL HUMAN; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0032812204     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(99)00064-8     Document Type: Article

References (4)

1. Surrey E., Judd H. Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotrophin releasing hormone agonist therapy of symptomatic endometriosis: A prospective randomized trial. J Clin Endocrinol Metab. 75:1992;558-563.
2. Neves-e-Castro M., Correia C. Use of luteinizing hormone-releasing hormone analogs in non-neoplastic gynecologic conditions: Seminars in Reproductive Endocrinology. 5:1987;411-419.
3. Sorva R., Kuvsi T., Dunkel L., Taskinen M.R. Effect of endogenous sex steroid on serum lipoprotein and the risk of coronary heart disease in women. New Engl J Med. 316:1987;1105-1112.
4. Barbieri R.L. Hormone treatment of endometriosis: The estrogen threshold hypothesis. Am J Obstet Gynecol. 166:1992;740-745.